Loading clinical trials...
Loading clinical trials...
The study is a multi-centre, observational study which enrolls 150 IBS-C patients and 150 non-IBS-C patients in China.
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
AstraZeneca
Collaborators
NCT07091084 · Constipation, Cancer, and more
NCT05519683 · Irritable Bowel Syndrome With Constipation
NCT06196073 · Functional Constipation
NCT07103772 · Irritable Bowel Syndrome, Irritable Bowel Syndrome With Diarrhea, and more
NCT07536698 · Functional Constipation
Research Site
Beijing
Research Site
Guangzhou
Research Site
Guangzhou
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions